Literature DB >> 14081662

THE EFFECTS OF NEOSTIGMINE UPON GANGLION RESPONSES AFTER ADMINISTRATION OF BLOCKING DRUGS.

P A FENNER, J G HILTON.   

Abstract

The effects of block of autonomic ganglia by chlorisondamine and by hexamethonium, the administration of neostigmine and of atropine upon blood pressure, nervous transmission through the superior cervical ganglion, stimulation of autonomic ganglia by dimethylphenylpiperazinium, and the carotid occlusion reflex, have been studied in the dog anaesthetized with sodium pentobarbitone. The results of these studies have shown: (1) A ganglion blocking agent blocks synaptic transmission in the superior cervical ganglion at the same time as it lowers blood pressure. Neostigmine administered after ganglion-block raises the blood pressure without much change in the response to stimulation of the preganglionic cervical sympathetic nerve. (2) If the effects of preganglionic nerve stimulation are recorded as a contraction of the nictitating membrane, a ganglion-blocking agent also abolishes this response at the same time as it blocks the reflex rise in blood pressure produced by occlusion of both common carotid arteries. Neostigmine administered under these conditions does not affect the responses of the nictitating membrane, but restores the carotid occlusion reflex. This restoration of reflex activity is sensitive to atropine, as is the blood pressure rise. (3) At the same time that neostigmine restores the carotid occlusion reflex, there is no restoration of sensitivity of autonomic ganglia to chemical stimulation by dimethylphenylpiperazinium. In these animals atropine not only blocked the restored carotid occlusion reflex, but produced a further inhibition of the pressor response to dimethylphenylpiperazinium. It is concluded that neostigmine may raise blood pressure by partially restoring autonomic ganglionic transmission, but that total ganglionic function is not restored.

Entities:  

Keywords:  ATROPINE; BLOOD PRESSURE; CHLORISONDAMINE; DOGS; EXPERIMENTAL LAB STUDY; GANGLIA, AUTONOMIC; HEXAMETHONIUM COMPOUNDS; NEOSTIGMINE; NICTITATING MEMBRANE; PHARMACOLOGY; PHYSIOLOGY; REFLEX

Mesh:

Substances:

Year:  1963        PMID: 14081662      PMCID: PMC1703822          DOI: 10.1111/j.1476-5381.1963.tb01530.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  9 in total

1.  The pressor response to neostigmine after ganglionic blockade.

Authors:  J G HILTON
Journal:  J Pharmacol Exp Ther       Date:  1961-04       Impact factor: 4.030

2.  Nutritional aspects of calculus disease of the urinary tract.

Authors:  V RAMALINGASWAMI; A L AURORA
Journal:  Fed Proc       Date:  1961-03

3.  Pharmacodynamics of drugs affecting the blood pressure; structure-action relationships of quaternary ganglionic and parasympathetic drugs.

Authors:  J M VAN ROSSUM; E J ARIENS
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-02-01

4.  Ganglionic actions of neostigmine methylsulfate.

Authors:  J P LONG; J W ECKSTEIN
Journal:  J Pharmacol Exp Ther       Date:  1961-08       Impact factor: 4.030

5.  A ganglion stimulating action of neostigmine.

Authors:  D F MASON
Journal:  Br J Pharmacol Chemother       Date:  1962-02

6.  A study of sympathetic ganglionic stimulants.

Authors:  B LEVY; R P AHLQUIST
Journal:  J Pharmacol Exp Ther       Date:  1962-08       Impact factor: 4.030

7.  Depolarizing action of neostigmine at an autonomic ganglion.

Authors:  D F MASON
Journal:  Br J Pharmacol Chemother       Date:  1962-06

8.  The actions of several ganglion blocking agents on the postganglionic discharge induced by diisopropyl phosphorofluoridate (DFP) in sympathetic ganglia.

Authors:  R L VOLLE
Journal:  J Pharmacol Exp Ther       Date:  1962-01       Impact factor: 4.030

9.  Asynchronous postganglionic firing from the cat superior cervical sympathetic ganglion treated with neostigmine.

Authors:  C TAKESHIGE; R L VOLLE
Journal:  Br J Pharmacol Chemother       Date:  1963-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.